• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类胃肠道间质瘤的基因组和转录组图谱。

Genomic and transcriptomic landscape of human gastrointestinal stromal tumors.

机构信息

CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 200031, Shanghai, China.

Institute of Intelligent Medical Research (IIMR), BGI Genomics, 518083, Shenzhen, China.

出版信息

Nat Commun. 2024 Nov 3;15(1):9495. doi: 10.1038/s41467-024-53821-1.

DOI:10.1038/s41467-024-53821-1
PMID:39489749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11532483/
Abstract

Gastrointestinal stromal tumor (GISTs) are clinically heterogenous exhibiting varying degrees of disease aggressiveness in individual patients. We comprehensively describe the genomic and transcriptomic landscape of a cohort of 117 GISTs including 31 low-risk, 18 intermediate-risk, 29 high-risk, 34 metastatic and 5 neoadjuvant GISTs from 105 patients. GISTs have notably low tumor mutation burden but widespread copy number variations. Aggressive GISTs harbor remarkably more genomic aberrations than low-/intermediate-risk GISTs. Complex genomic alterations, chromothripsis and kataegis, occur selectively in aggressive GISTs. Despite the paucity of mutations, recurrent inactivating YLPM1 mutations are identified (10.3%, 7 of 68 patients), enriched in high-risk/metastatic GIST and functional study further demonstrates YLPM1 inactivation promotes GIST proliferation, growth and oxidative phosphorylation. Spatially and temporally separated GISTs from individual patients demonstrate complex tumor heterogeneity in metastatic GISTs. Finally, four prominent subtypes are proposed with different genomic features, expression profiles, immune characteristics, clinical characteristics and subtype-specific treatment strategies. This large-scale analysis depicts the landscape and provides further insights into GIST pathogenesis and precise treatment.

摘要

胃肠道间质瘤(GISTs)在临床上表现出异质性,在个体患者中表现出不同程度的疾病侵袭性。我们全面描述了 117 例 GIST 患者的基因组和转录组图谱,其中包括 31 例低危、18 例中危、29 例高危、34 例转移性和 5 例新辅助 GISTs,来自 105 例患者。GISTs 的肿瘤突变负担明显较低,但存在广泛的拷贝数变异。侵袭性 GISTs 比低/中危 GISTs 具有更多的基因组异常。复杂的基因组改变、染色体碎裂和kataegis 选择性地发生在侵袭性 GISTs 中。尽管突变很少,但在高危/转移性 GIST 中鉴定到了反复出现的 YLPM1 失活突变(10.3%,68 例患者中的 7 例),功能研究进一步表明 YLPM1 失活促进了 GIST 的增殖、生长和氧化磷酸化。来自个体患者的空间和时间分离的 GISTs 在转移性 GIST 中表现出复杂的肿瘤异质性。最后,提出了四个突出的亚型,具有不同的基因组特征、表达谱、免疫特征、临床特征和亚型特异性治疗策略。这项大规模分析描绘了景观,并进一步深入了解 GIST 的发病机制和精确治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/9cbafea89bc8/41467_2024_53821_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/ecb83fc23ca8/41467_2024_53821_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/53f486954f66/41467_2024_53821_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/34cc7100f936/41467_2024_53821_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/0cbe851250e9/41467_2024_53821_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/524a8cf77e53/41467_2024_53821_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/4e386b6fe18a/41467_2024_53821_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/9cbafea89bc8/41467_2024_53821_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/ecb83fc23ca8/41467_2024_53821_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/53f486954f66/41467_2024_53821_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/34cc7100f936/41467_2024_53821_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/0cbe851250e9/41467_2024_53821_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/524a8cf77e53/41467_2024_53821_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/4e386b6fe18a/41467_2024_53821_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bf/11532483/9cbafea89bc8/41467_2024_53821_Fig7_HTML.jpg

相似文献

1
Genomic and transcriptomic landscape of human gastrointestinal stromal tumors.人类胃肠道间质瘤的基因组和转录组图谱。
Nat Commun. 2024 Nov 3;15(1):9495. doi: 10.1038/s41467-024-53821-1.
2
Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors.胃肠道间质瘤的全基因组DNA甲基化和拷贝数改变
Genes Chromosomes Cancer. 2025 Mar;64(3):e70046. doi: 10.1002/gcc.70046.
3
SETD2 histone modifier loss in aggressive GI stromal tumours.SETD2 组蛋白修饰酶缺失与侵袭性胃肠道间质瘤。
Gut. 2016 Dec;65(12):1960-1972. doi: 10.1136/gutjnl-2015-309482. Epub 2015 Sep 3.
4
High density DNA array analysis reveals distinct genomic profiles in a subset of gastrointestinal stromal tumors.高密度DNA阵列分析揭示了一部分胃肠道间质瘤中不同的基因组图谱。
Genes Chromosomes Cancer. 2009 Oct;48(10):886-96. doi: 10.1002/gcc.20689.
5
Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumors.综合基因组分析确定了胃肠道间质瘤中频繁发生的基因融合事件和VHL失活。
Oncotarget. 2016 Feb 9;7(6):6538-51. doi: 10.18632/oncotarget.3731.
6
GSTT1 copy number gain and ZNF overexpression are predictors of poor response to imatinib in gastrointestinal stromal tumors.GSTT1 拷贝数增加和 ZNF 过表达是胃肠间质瘤对伊马替尼反应不良的预测因子。
PLoS One. 2013 Oct 4;8(10):e77219. doi: 10.1371/journal.pone.0077219. eCollection 2013.
7
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.一大组胃肠道间质瘤(GISTs)的临床病理和分子特征及文献综述:KIT/PDGFRA野生型GISTs中的BRAF突变是罕见事件。
Hum Pathol. 2017 Apr;62:206-214. doi: 10.1016/j.humpath.2017.01.005. Epub 2017 Feb 1.
8
Expression profiles of stemness genes in gastrointestinal stromal tumor.胃肠道间质瘤中干性基因的表达谱。
Hum Pathol. 2018 Jun;76:76-84. doi: 10.1016/j.humpath.2018.02.015. Epub 2018 Feb 25.
9
Comprehensive Genomic Assessment of Advanced-Stage GI Stromal Tumors Using the Japanese National Center for Cancer Genomics and Advanced Therapeutics Database.利用日本国家癌症基因组学和先进治疗学数据库对晚期胃肠道间质瘤进行全面基因组评估。
JCO Precis Oncol. 2024 Oct;8:e2400284. doi: 10.1200/PO.24.00284. Epub 2024 Oct 24.
10
Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.RB1和TP53的失活突变与胃肠道间质瘤的肉瘤样组织形态学及转移/复发相关。
Am J Clin Pathol. 2016 Dec;146(6):718-726. doi: 10.1093/ajcp/aqw193. Epub 2016 Dec 27.

引用本文的文献

1
Applications and advances of multi-omics technologies in gastrointestinal tumors.多组学技术在胃肠道肿瘤中的应用与进展
Front Med (Lausanne). 2025 Jul 23;12:1630788. doi: 10.3389/fmed.2025.1630788. eCollection 2025.
2
Immunotherapy in gastrointestinal stromal tumors: Current landscape and future horizons.胃肠道间质瘤的免疫治疗:现状与未来展望
World J Clin Oncol. 2025 Jun 24;16(6):104314. doi: 10.5306/wjco.v16.i6.104314.
3
Establishment and validation of a prognostic nomogram for extra-gastrointestinal stromal tumors.

本文引用的文献

1
Uncovering novel mutational signatures by extraction with SigProfilerExtractor.通过SigProfilerExtractor提取来揭示新的突变特征。
Cell Genom. 2022 Nov 9;2(11):None. doi: 10.1016/j.xgen.2022.100179.
2
Signatures of copy number alterations in human cancer.人类癌症中拷贝数改变的特征。
Nature. 2022 Jun;606(7916):984-991. doi: 10.1038/s41586-022-04738-6. Epub 2022 Jun 15.
3
Examining clustered somatic mutations with SigProfilerClusters.使用 SigProfilerClusters 检测聚集性体细胞突变
胃肠道外间质瘤预后列线图的建立与验证
Front Oncol. 2025 Mar 20;15:1527237. doi: 10.3389/fonc.2025.1527237. eCollection 2025.
Bioinformatics. 2022 Jun 27;38(13):3470-3473. doi: 10.1093/bioinformatics/btac335.
4
The nerve-tumour regulatory axis GDNF-GFRA1 promotes tumour dormancy, imatinib resistance and local recurrence of gastrointestinal stromal tumours by achieving autophagic flux.神经肿瘤调控轴 GDNF-GFRA1 通过实现自噬流促进胃肠道间质瘤的肿瘤休眠、伊马替尼耐药和局部复发。
Cancer Lett. 2022 Jun 1;535:215639. doi: 10.1016/j.canlet.2022.215639. Epub 2022 Mar 11.
5
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients.25000 例患者前瞻性临床测序的转移模式的基因组特征分析。
Cell. 2022 Feb 3;185(3):563-575.e11. doi: 10.1016/j.cell.2022.01.003.
6
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis.铜耗竭调节线粒体氧化磷酸化以损害三阴性乳腺癌转移。
Nat Commun. 2021 Dec 15;12(1):7311. doi: 10.1038/s41467-021-27559-z.
7
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors.纳武利尤单抗单药或联合伊匹木单抗治疗晚期胃肠道间质瘤患者的随机 II 期研究。
Clin Cancer Res. 2022 Jan 1;28(1):84-94. doi: 10.1158/1078-0432.CCR-21-0878. Epub 2021 Aug 18.
8
Gastrointestinal stromal tumours.胃肠道间质瘤。
Nat Rev Dis Primers. 2021 Mar 18;7(1):22. doi: 10.1038/s41572-021-00254-5.
9
Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain.继发于 PDGFRA 激酶结构域的突变导致 PDGFRA 驱动的 GIST 对阿伐普利尼耐药。
Cancer Discov. 2021 Jan;11(1):108-125. doi: 10.1158/2159-8290.CD-20-0487. Epub 2020 Sep 24.
10
Clinical Challenges of Immune Checkpoint Inhibitors.免疫检查点抑制剂的临床挑战。
Cancer Cell. 2020 Sep 14;38(3):326-333. doi: 10.1016/j.ccell.2020.07.004. Epub 2020 Aug 3.